Patrizia Tempora | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Combining ERAP1 silencing and entinostat therapy to overcome resistance to cancer immunotherapy in neuroblastoma	JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH	2024
Two bullets in the gun: combining immunotherapy with chemotherapy to defeat neuroblastoma by targeting adrenergic-mesenchymal plasticity	FRONTIERS IN IMMUNOLOGY	2023
Targeting the antigen processing and presentation pathway to overcome resistance to immune checkpoint therapy	FRONTIERS IN IMMUNOLOGY	2022
Combined mitoxantrone and anti-TGFβ treatment with PD-1 blockade enhances antitumor immunity by remodelling the tumor immune landscape in neuroblastoma	JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH	2022
ERAP1 and ERAP2 enzymes: A protective shield for ras against COVID-19?	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2021
Dendritic cells: Behind the scenes of t-cell infiltration into the tumor microenvironment	CANCERS	2021
ERAP1 Controls the Interaction of the Inhibitory Receptor KIR3DL1 With HLA-B51:01 by Affecting Natural Killer Cell Function	FRONTIERS IN IMMUNOLOGY	2021
ERAP1 Controls the Interaction of the Inhibitory Receptor KIR3DL1 With HLA-B51:01 by Affecting Natural Killer Cell Function	FRONTIERS IN IMMUNOLOGY	2021
Impact of Natural Occurring ERAP1 Single Nucleotide Polymorphisms within miRNA-Binding Sites on HCMV Infection	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2020